BMC Medicine

official impact factor 5.75

Open Access Research article

Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study

Zhe Zhang, Xiaoyun Zhou, Hujia Shen, Dexing Wang and Yanhong Wang*

BMC Medicine 2009, 7:41 doi:10.1186/1741-7015-7-41

Accesses  

  • Last 30 days: 99 accesses
  • Last 365 days: 1026 accesses
  • All time: 4212 accesses

Cited by